|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
|
|---|---|---|---|---|---|---|
| Current assets: | ||||||
| Cash and cash equivalents | ||||||
| Prepaid expenses | ||||||
| Total current assets | ||||||
| Investments held in Trust Account | ||||||
| Total assets | ||||||
| Current liabilities: | ||||||
| Accounts payable (including approximately $0 and $75,000 of offering costs at June 30, 2026 and December 31, 2025, respectively) | ||||||
| Accrued liabilities | ||||||
| Deferred compensation – related parties | ||||||
| Total current liabilities | ||||||
| Other liabilities: | ||||||
| Deferred underwriting fee payable | ||||||
| Total liabilities | ||||||
| Class A ordinary shares subject to possible redemption; 20,125,000 and 20,125,000 shares at $10.58 and $10.40 per share at June 30, 2026 and December 31, 2025, respectively | ||||||
| Class A Ordinary Shares | ||||||
| Total class A ordinary shares subject to possible redemption; 20,125,000 and 20,125,000 shares at $10.58 and $10.40 per share at June 30, 2026 and December 31, 2025, respectively | ||||||
| Shareholders’ deficit: | ||||||
| Ordinary shares, value | ||||||
| Accumulated deficit | ||||||
| Total shareholders’ deficit | ||||||
| Total liabilities, Class A ordinary shares subject to possible redemption and shareholders’ deficit |
Loading...
